R. Shanti
Papers
1
Total Citations
2
H-Index
1
About
Dr. R. Shanti is a leading surgical oncologist whose research focuses on the de-intensification of treatment for human papillomavirus (HPV)-related oropharyngeal cancers, particularly through the integration of transoral robotic surgery (TORS). Her most cited work, a Phase II study from 2022, investigates volume and dose de-intensification following TORS and neck dissection for p16+ oropharyngeal squamous cell carcinoma. This landmark contribution addresses the critical challenge of reducing long-term toxicities—such as dysphagia and xerostomia—without compromising oncologic outcomes in a patient population with generally favorable prognoses. Although early in its citation impact (2 citations), the study represents a paradigm-shifting approach that has influenced clinical trial design and surgical protocols. Dr. Shanti’s work bridges the gap between surgical precision and personalized radiotherapy, offering a roadmap for safer, more targeted care. Her research is particularly notable for its patient-centered focus, aiming to preserve quality of life while maintaining high cure rates. As a rising voice in head and neck oncology, Dr. Shanti continues to shape the future of de-escalation strategies, making her a key figure for students and researchers interested in the intersection of surgery, radiation oncology, and HPV-related disease management.
Research Focus
Key Achievements
Top Papers
- 1